Prostate Cell News Volume 17.11 | Jun 26 2026

    0
    24






    2026-06-26 | PCN 17.11


    Prostate Cell News by STEMCELL Technologies
    Vol. 17.11 – 26 June, 2026
    TOP STORY

    Targeting Oncogenic TβRI Signaling Inhibits Androgen-Independent Prostate Cancer Growth and Metastasis

    In a preclinical human orthotopic metastatic CRPC mouse model, treatment with therapeutic monoclonal antibodies effectively prevents the nuclear accumulation of TβRI-ICD, inhibits epithelial-to-mesenchymal transition, and suppresses tumor growth, invasion, and metastasis.
    [Signal Transduction and Targeted Therapy]

    Full Article
    Enter your awe-inspiring image in the #StemCellfie contest for a chance to win!
    PUBLICATIONSListed by the impact factor of the journal

    Programmable mRNA 3′UTR Engineering Restores MHC-I and Overcomes Immune Evasion in Prostate Cancer

    Investigators developed a programmable RNA engineering platform, termed the 3′UTR CRISPR/dCas13 Engineering System, to precisely manipulate mRNA alternative polyadenylation in vivo.
    [Nature Biomedical Engineering]

    Full Article

    Recurrent Intra-Tumor Heterogeneity Is a Hallmark of Metastatic Prostate Cancer

    To define mechanisms underpinning metastatic heterogeneity in late-stage disease, scientists employed single-cell multi-omics and whole-genome sequencing to deeply profile 34 metastatic lesions obtained from patients through rapid autopsy.
    [Nature Communications]

    Abstract

    Identification of Targets of Clinical FOXA1 Mutants Involved in EMT and Immune Suppression in Prostate Cancer

    Researchers provided distinct insight into how FOXA1 forkhead DNA-binding domain (FKHD) mutations drive prostate cancer progression and highlighted potential therapeutic targets in tumors.
    [Communications Biology]

    Abstract

    ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer

    Investigators uncovered a previously unrecognized triad of ERG-driven processes –dedifferentiation, senescence, and inflammation– that may underpin its oncogenic potential and shape prostate cancer initiation and therapeutic response.
    [Molecular Cancer Research]

    Abstract

    MicroRNA-6833-3p Drives Prostate Cancer Progression and Stemness by Targeting the NUMB-Mediated NOTCH Signaling Pathway

    Scientists revealed that miR-6833-3p drives prostate carcinogenesis and enhances tumor-initiating cell properties through suppression of the NUMB-mediated NOTCH signaling axis.
    [Cell Cycle]

    Abstract
    REVIEWS

    Mechanisms of Resistance to Androgen Deprivation Therapy in Prostate Cancer

    The authors summarize the key molecular drivers of prostate cancer resistance and evaluate emerging invasive biomarkers with potential clinical utility.
    [Molecular Aspects of Medicine]

    Abstract

    The Glycobiology of Prostate Cancer: An Update

    Scientists discuss the role of glycans in fundamental mechanisms controlling prostate cancer growth, metastasis, and immune evasion.
    [Oncogene]

    Full Article
    INDUSTRY AND POLICY NEWS

    UCLA Researchers Awarded $1.7 Million Department of Defense Grant to Advance Next-Generation CAR T Cell Therapies for Prostate Cancer

    Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.7 million grant to develop new strategies to improve CAR T-cell therapies for metastatic CRPC.
    [UCLA Health]

    Press Release
    FEATURED EVENT

    5th In Vivo Cell Engineering & Gene Editing Summit

    July 28 – 30, 2026
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Whole Genome Duplication in Prostate Cancer

    University of Oxford- Oxford, England, United Kingdom

    Research Assistant – Bone Oncology Research Group

    University of Oxford – Oxford, England, United States

    Postdoctoral Fellow/Staff Scientist – Prostate Cancer

    City of Hope – Duarte, California, United States

    Postdoctoral Fellowships – Computational Biology

    The University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Tenure-Track Professor/Associate Professor/Assistant Professor – Biomedical Sciences

    The University of Hong Kong – Hong Kong

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2